A bill introduced in the U.S. House of Representatives would loosen federal restrictions on access to medication for opioid use disorder. The Improving Access to Care and Treatment (IMPACT) Act would increase the amount of time prescribers may store long-acting injectable (LAI) buprenorphine dispensed from a specialty pharmacy for administration to their patients.
Today, the Office of National Drug Control Policy (ONDCP) announced the release of a model law for state legislatures that would help ensure opioid litigation proceeds are directed to addressing substance use disorders and drug-related harms in impacted communities and with public accountability.
Mississippi’s ban on nearly all abortions after 15 weeks forces women to carry pregnancies to term under adverse circumstances and increases the risk of maternal mortality and other health problems, according to a public health amicus brief filed in the United States Supreme Court on September 20.
Thank you to @RepDean, @RepSpartz, @RepMGS, and @RepFitzpatrick for leading U.S. House efforts to increase access to individualized treatment for #opioid use disorder. #MOUD #14to60 https://dean.house.gov/2021/11/reps-dean-spartz-scanlon-and-fitzpatrick-introduce-the-improving-access-to-care-and-treatment-impact-act
We especially appreciate the emphasis on #compassion for people with #addiction and those who love them. @HHSGov @ONDCP https://www.foxnews.com/politics/biden-admin-overdose-prevention-strategy
Congrats to @PADrugAlcohol Sec. Jen Smith, recipient of #NASADAD nat'l service award. Under @GovernorTomWolf & Sec. Smith, #Pennsylvania has set a nationwide example by implementing emergency dep't #WarmHandoff programs in 95% of hospitals. 👍👍https://www.connectradio.fm/2021/10/17/pa-drug-and-alcohol-secretary-awarded-national-service-award/
